Department of Obstetrics and Gynecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Department of Pediatrics, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Int J Environ Res Public Health. 2022 Apr 25;19(9):5201. doi: 10.3390/ijerph19095201.
This exploratory study aimed to evaluate the effects of antenatal corticosteroids in singleton pregnancies of Asian women prior to elective cesarean section (CS) at early term on neonatal respiratory outcomes.
This is a pilot and pragmatic randomized trial conducted at a university hospital in Malaysia. Women with singleton pregnancies planned for elective CS between 37 and 38 weeks gestation were randomly allocated into the intervention group, where they received two doses of IM dexamethasone 12 mg of 12 h apart, 24 h prior to surgery OR into the standard care, control group, and both groups received the normal routine antenatal care. The primary outcome measures were neonatal respiratory illnesses, NICU admission and length of stay.
A total of 189 patients were recruited, 93 women in the intervention group and 96 as controls. Between the steroid and control groups, the mean gestation at CS was similar, 266.1 ± 3.2 days (38 weeks) vs. 265.8 ± 4.0 days (37 weeks), = 0.53. The mean birthweight of infants was 3.06 ± 0.41 kg vs. 3.04 ± 0.37 kg, = 0.71. Infants with respiratory morbidities were primarily due to transient tachypnea of newborn (9.7% vs. 6.3%), and congenital pneumonia (1.1% vs. 3.1%) but none had respiratory distress syndrome. Only four infants required NICU admission (2.2% vs. 3.1%, = 0.63). Their average length of stay was not statistically different; 3.5 ± 2.1 days vs. 5.7 ± 1.5 days, = 0.27.
Elective CS at early term before 39 weeks was associated with a modest overall incidence of neonatal respiratory illness (10.1%) in this Asian population. Antenatal dexamethasone did not diminish infants needing respiratory support, NICU admission and length of stay.
本探索性研究旨在评估在马来西亚一所大学医院进行的选择性剖宫产(CS)前,对亚洲女性的单胎妊娠进行产前皮质类固醇治疗对新生儿呼吸结局的影响。
这是一项在马来西亚一所大学医院进行的试点和实用随机试验。计划在 37 至 38 周妊娠时进行选择性 CS 的单胎妊娠妇女被随机分配到干预组,她们在手术前 24 小时内接受两次 IM 地塞米松 12 毫克,间隔 12 小时,或接受标准护理对照组,两组均接受正常的常规产前护理。主要结局指标是新生儿呼吸疾病、新生儿重症监护病房(NICU)入院和住院时间。
共招募了 189 名患者,干预组 93 名,对照组 96 名。在类固醇组和对照组之间,CS 的平均孕龄相似,分别为 266.1 ± 3.2 天(38 周)和 265.8 ± 4.0 天(37 周), = 0.53。婴儿的平均出生体重为 3.06 ± 0.41 千克,3.04 ± 0.37 千克, = 0.71。有呼吸疾病的婴儿主要是由于新生儿短暂性呼吸急促(9.7%比 6.3%)和先天性肺炎(1.1%比 3.1%),但没有呼吸窘迫综合征。只有 4 名婴儿需要 NICU 入院(2.2%比 3.1%, = 0.63)。他们的平均住院时间没有统计学差异;3.5 ± 2.1 天比 5.7 ± 1.5 天, = 0.27。
在亚洲人群中,在 39 周前进行早期选择性 CS 与新生儿呼吸疾病(10.1%)的总体发生率适度相关。产前地塞米松并没有减少需要呼吸支持、NICU 入院和住院时间的婴儿。